Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma.
Kinoshita M, Fushimi Y, Masumoto T, Sasaki K, Sekita T, Natsume A, Wakabashi T, Komori T, Tsuzuki S, Muragaki Y, Motomura K, Saito R, Sato K, Beppu T, Takahashi M, Kuroda JI, Sonoda Y, Kobayashi K, Mishima K, Mitsuya K, Yamasaki F, Inoue A, Matsutani T, Nakamura H, Yamaguchi S, Ishikawa E, Nakaya M, Tanaka S, Ujifuku K, Uchida H, Kanamori M, Otani R, Kijima N, Nishida N, Yoshino A, Mineharu Y, Arakawa Y, Fukuda H, Narita Y; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Kinoshita M, et al. Among authors: mineharu y. Magn Reson Med Sci. 2024 Nov 19. doi: 10.2463/mrms.mp.2024-0103. Online ahead of print. Magn Reson Med Sci. 2024. PMID: 39567017 Free article.
Postoperative Karnofsky performance status prediction in patients with IDH wild-type glioblastoma: A multimodal approach integrating clinical and deep imaging features.
Sasagasako T, Ueda A, Mineharu Y, Mochizuki Y, Doi S, Park S, Terada Y, Sano N, Tanji M, Arakawa Y, Okuno Y. Sasagasako T, et al. Among authors: mineharu y. PLoS One. 2024 Nov 11;19(11):e0303002. doi: 10.1371/journal.pone.0303002. eCollection 2024. PLoS One. 2024. PMID: 39527541 Free PMC article.
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S, Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J, Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H, Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H, Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T, Endo H, Tominaga T. Kanamori M, et al. Among authors: mineharu y. Int J Clin Oncol. 2024 Nov 11. doi: 10.1007/s10147-024-02650-9. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39527165
Phase II Trial of Pathology-based Tripartite Treatment Stratification for Patients with CNS Germ Cell Tumors: A Long-term Follow-up Study.
Takami H, Matsutani M, Suzuki T, Takabatake K, Fujimaki T, Okamoto M, Yamaguchi S, Kanamori M, Matsuda K, Sonoda Y, Natsumeda M, Ichinose T, Nakada M, Muroi A, Ishikawa E, Takahashi M, Narita Y, Tanaka S, Saito N, Higuchi F, Shin M, Mineharu Y, Arakawa Y, Kagawa N, Kawabata S, Wanibuchi M, Takayasu T, Yamasaki F, Fujii K, Ishida J, Date I, Miyake K, Fujioka Y, Kuga D, Yamashita S, Takeshima H, Shinojima N, Mukasa A, Asai A, Nishikawa R. Takami H, et al. Among authors: mineharu y. Neuro Oncol. 2024 Nov 2:noae229. doi: 10.1093/neuonc/noae229. Online ahead of print. Neuro Oncol. 2024. PMID: 39492661
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.
Motomura K, Sasaki K, Sugii N, Yamaguchi S, Inoue H, Oshima A, Tanaka K, Otani Y, Shirahata M, Shibahara I, Nagane M, Tsuzuki S, Matsutani T, Tsukamoto Y, Kijima N, Asano K, Ohno M, Inoue A, Mineharu Y, Miyake K, Mitobe Y, Hanihara M, Kawanishi Y, Deguchi S, Saito M, Matsuda R, Ujifuku K, Arita H, Sato Y, Yamashita S, Yonezawa U, Yamaguchi J, Momii Y, Ogawa T, Kambe A, Ohba S, Fukai J, Saito N, Kinoshita M, Sumi K, Otani R, Uzuka T, Takebe N, Koizumi S, Saito R, Arakawa Y, Narita Y; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Motomura K, et al. Among authors: mineharu y. Jpn J Clin Oncol. 2024 Oct 3;54(10):1123-1131. doi: 10.1093/jjco/hyae116. Jpn J Clin Oncol. 2024. PMID: 39223700 Free PMC article.
Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients.
Hosoya K, Ozasa H, Tanji M, Yoshida H, Ajimizu H, Tsuji T, Yoshida H, Terada Y, Sano N, Mineharu Y, Miyamoto S, Hirai T, Arakawa Y. Hosoya K, et al. Among authors: mineharu y. BMC Cancer. 2024 Aug 21;24(1):1030. doi: 10.1186/s12885-024-12798-2. BMC Cancer. 2024. PMID: 39169327 Free PMC article.
Trochlear nerve schwannoma with concomitant osimertinib-responsive stage IV lung adenocarcinoma: illustrative case.
Kashiwagi S, Tanji M, Matsuoka T, Sano N, Ozasa H, Natori D, Takeuchi Y, Makino Y, Yamamoto Hattori E, Terada Y, Mineharu Y, Arakawa Y. Kashiwagi S, et al. Among authors: mineharu y. J Neurosurg Case Lessons. 2024 Aug 12;8(7):CASE24144. doi: 10.3171/CASE24144. Print 2024 Aug 12. J Neurosurg Case Lessons. 2024. PMID: 39133949 Free PMC article.
Hypofractionated radiotherapy combined with bevacizumab plus low-dose ifosfamide, carboplatin, and etoposide as second-line chemoradiotherapy for progressing spinal diffuse midline glioma, H3K27-altered: illustrative case.
Nakayasu S, Tanji M, Uto M, Takeuchi Y, Makino Y, Yamamoto Hattori E, Terada Y, Sano N, Mineharu Y, Mizowaki T, Arakawa Y. Nakayasu S, et al. Among authors: mineharu y. J Neurosurg Case Lessons. 2024 Aug 12;8(7):CASE2464. doi: 10.3171/CASE2464. Print 2024 Aug 12. J Neurosurg Case Lessons. 2024. PMID: 39133948 Free PMC article.
135 results